---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-233450"
form_type: "8-K"
ticker: "SCLX"
cik: "0001820190"
company_name: "Scilex Holding Co"
filed_at: "2025-10-07T23:59:59+00:00"
generated_at: "2026-05-17T04:28:46.653309+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Scilex appoints Stephen Ma as COO; he continues as CFO

## Summary
- Stephen Ma, 53, appointed COO effective Oct 1, 2025; retains CFO, SVP, Corporate Secretary, and Board roles.
- Ma has 15+ years finance/operations experience in pharma and venture-backed biotech.
- Also appointed CFO of Semnur Pharmaceuticals (OTC:SMNR) on Sep 22, 2025.
- No change in compensation for his COO appointment; standard indemnification agreement in place.

## SEC filing metadata
- accession: 0001193125-25-233450
- form_type: 8-K
- ticker: SCLX
- cik: 0001820190
- company_name: Scilex Holding Co
- filed_at: 2025-10-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1820190/000119312525233450/0001193125-25-233450-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1820190/000119312525233450/sclx-20251001.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-233450
- JSON: https://secwatch.observer/filing/0001193125-25-233450.json
- Plain text: https://secwatch.observer/filing/0001193125-25-233450.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.